5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

FDC Ltd.

•
fdcindia.comBSE: 531599NSE: FDC
Market Cap₹ 5,549 Cr.
Current Price
High / Low₹ 528 / 313
Stock P/E18.8
Book Value₹ 161
Price to Book2.10
Dividend Yield1.47 %
ROCE16.0 %
ROE12.0 %
Face Value₹ 1

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Company is almost debt free
  • Company generates healthy free cash flow
  • Stock looks reasonably valued - P/E of 18.8 is below its historical median

CONS

  • Receivables are growing faster than sales - a possible quality concern
  • A large part of profit comes from other income (29.3% of PBT)
  • Recent results are weak - TTM profit is down 10.7% versus prior year
  • Company has delivered a poor profit growth of -0.6% over past five years

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs
Part ofNIFTY 50NIFTY 500NIFTY LARGEMIDCAP 250NIFTY 100NIFTY 200
S.No.Name
1.SUNPHARMA1842.0036.54441957.500.872901.2326.5315299.8810.9819.1128.81
2.DIVISLAB9326.0084.64247576.000.32902.0065.503080.0027.8021.5140.75
3.TORNTPHARM4975.0086.76189233.010.76566.003.284921.0057.3219.2733.81
4.ZYDUSLIFE1119.5024.74111670.550.09990.20-34.908017.0023.9721.3924.54
5.CIPLA1365.0032.72110272.680.95785.55-39.187119.284.1316.0016.73
6.LAURUSLABS1970.3597.37106460.420.10362.07123.942026.3129.1018.2031.50
7.DRREDDY1161.0030.0796906.380.69435.60-69.108099.80-5.2113.7510.63
8.AUROPHARMA1675.4525.9796401.690.241032.0325.229150.3517.4412.7620.54
9.LUPIN2096.0017.3495842.920.861416.9816.018276.8934.2828.8629.59
10.MANKIND2277.0046.0494050.370.04574.0929.124030.5912.8913.2426.30
11.GLENMARK2416.9037.9468210.880.10482.83927.884018.4831.3520.3520.03
12.FDC340.8518.975549.381.47132.499.18667.692.9715.9321.42
Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
530480452454624505459482642462458564655
410401370396482433413429501427408453528
Operating Profit1207982581427246531413550112127
OPM %22.64%16.41%18.11%12.73%22.70%14.33%10.01%10.96%22.00%7.56%10.83%19.78%19.38%
3027252128351931362114747
Interest1111111111121
Depreciation10101010111413161515151415
Profit before Tax1399596671589250681613935143174
Tax %22.00%24.35%18.64%28.30%27.02%19.82%27.56%28.62%24.05%25.37%22.39%25.10%24.24%
Net Profit1097278481157436481222927107132
6.544.364.812.977.064.552.242.967.511.811.676.588.11

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
1,0091,0621,0761,3311,3251,5191,7771,9162,0702,1262,139
7678438561,0481,0011,2721,5241,5781,7501,7741,816
Operating Profit242219220284324247253338320352323
OPM %23.98%20.63%20.45%21.30%24.47%16.25%14.25%17.66%15.47%16.56%15.10%
4451518397795510310690117
Interest11133344455
Depreciation3535333738373940545959
Profit before Tax250234236325380285266398368378392
Tax %25.11%28.04%27.41%24.18%22.59%23.06%24.36%22.81%25.58%24.43%24.51%
Net Profit187168172247294220201307274286296
EPS10.529.479.8414.3417.3213.0112.0918.8716.8117.56—
Dividend Payout %21.39%0.00%0.00%5.54%0.00%0.00%0.00%0.00%29.75%28.47%—

COMPOUNDED SALES GROWTH

10 Years:
8%
5 Years:
10%
3 Years:
6%

COMPOUNDED PROFIT GROWTH

10 Years:
5%
5 Years:
-1%
3 Years:
12%

STOCK PRICE CAGR

10 Years:
4%
5 Years:
0%
3 Years:
-3%
1 Year:
-27%

RETURN ON EQUITY

10 Years:
14%
5 Years:
12%
3 Years:
13%
Last Year:
12%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Corporate actions

2023

Aug 25

₹ 500.00

The Board has decided August 25, 2023 as the record date for the purpose of Buyback offer

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital18171717171717161616
1,2461,2451,4161,5251,7051,9321,9642,0812,2712,476
4521072520121211
Trade Payables75977711877136178185202200
5265866447508369129931,0131,1391,229
Total Liabilities1,8681,9502,1562,4192,6423,0223,1723,3073,6403,932
674670678670685701695676848994
Capital Work in Progress31012241910419826113696
4914725856657908868068501,0501,070
136160173209213304323383368344
0000000115104142
Cash & Bank23211629273221224139
5396186928229079951,1291,0001,0941,247
Total Assets1,8681,9502,1562,4192,6423,0223,1723,3073,6403,932

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
226216175323304241242221310200
Cash from Investing-14420-109-85-84-1474-18-199-109
Cash from Financing0-169-0-142-126-10-180-202-92-93
10-2-612-15-11119-2

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
69.6669.6669.6669.6669.6669.6669.6669.6669.66
2.512.622.672.562.412.442.322.401.40
6.726.036.086.377.176.816.276.296.31
Government0.000.000.000.000.000.000.000.000.00
21.1021.7021.5921.4220.7621.1021.7521.6522.63

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-04
Copy of Newspaper Publication

2026-09-04 - FDC Limited has informed the Exchange about Copy of Newspaper Publication

2026-09-01
Record Date

2026-09-01 - FDC Limited has informed the Exchange that Record date for the purpose of Meeting is 16-Sep-2026.

2026-09-01
Shareholders meeting

2026-09-01 - FDC Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 24, 2026

2026-09-01
Copy of Newspaper Publication

2026-09-01 - FDC Limited has informed the Exchange about the newspaper publication in respect of the 86th AGM.

2026-08-27
General Updates

2026-08-27 - FDC Limited has informed the Exchange about Interim Stay received from The Honourable High Court of Delhi, New Delhi

2026-08-13
General Updates

2026-08-13 - FDC Limited has informed the Exchange about Marketing Authorisation received by its subsidiary, FDC International Ltd, from MHRA, UK, for Atropine 1.0% w/v Eye Drops, Solution.

2026-08-05
Press Release

2026-08-05 - FDC Limited has informed the Exchange regarding a press release dated August 05, 2026, titled "Press Release Q1 FY 2026-2027 Results".

2026-08-05
Outcome of Board Meeting

2026-08-05 - FDC Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

2026-07-27
Certificate under SEBI (Depositories and Participants) Regulations, 2018

2026-07-27 - FDC Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

News

Recent coverage and analyst commentary for FDC

Loading news…

🤖

AI Stock Analyst

FDC Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login